Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin
- PMID: 7541539
- PMCID: PMC41520
- DOI: 10.1073/pnas.92.14.6374
Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin
Abstract
A number of factors both stimulating and inhibiting angiogenesis have been described. In the current work, we demonstrate that the angiogenic factor vascular endothelial growth factor (VEGF) activates mitogen-activated protein kinase (MAPK) as has been previously shown for basic fibroblast growth factor. The antiagiogenic factor 16-kDa N-terminal fragment of human prolactin inhibits activation of MAPK distal to autophosphorylation of the putative VEGF receptor, Flk-1, and phospholipase C-gamma. These data show that activation and inhibition of MAPK may play a central role in the control of angiogenesis.
Similar articles
-
cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation.J Cell Biochem. 1997 Dec 1;67(3):353-66. J Cell Biochem. 1997. PMID: 9361190
-
Angiostatin diminishes activation of the mitogen-activated protein kinases ERK-1 and ERK-2 in human dermal microvascular endothelial cells.J Vasc Res. 1999 Jan-Feb;36(1):28-34. doi: 10.1159/000025623. J Vasc Res. 1999. PMID: 10050071
-
16K human prolactin inhibits vascular endothelial growth factor-induced activation of Ras in capillary endothelial cells.Mol Endocrinol. 1999 May;13(5):692-704. doi: 10.1210/mend.13.5.0280. Mol Endocrinol. 1999. PMID: 10319320
-
Eicosapentaenoic acid attenuates vascular endothelial growth factor-induced proliferation via inhibiting Flk-1 receptor expression in bovine carotid artery endothelial cells.J Cell Physiol. 1998 Aug;176(2):342-9. doi: 10.1002/(SICI)1097-4652(199808)176:2<342::AID-JCP12>3.0.CO;2-5. J Cell Physiol. 1998. PMID: 9648921
-
Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.Cancer Res. 1998 Mar 15;58(6):1278-84. Cancer Res. 1998. PMID: 9515816
Cited by
-
Regulation of Tumor Angiogenesis and Choroidal Neovascularization by Endogenous Angioinhibitors.J Cancer Sci Ther. 2013 Jul 4;5(12):417-426. doi: 10.4172/1948-5956.1000235. J Cancer Sci Ther. 2013. PMID: 25258675 Free PMC article.
-
Oligonucleotide NX1838 inhibits VEGF165-mediated cellular responses in vitro.In Vitro Cell Dev Biol Anim. 1999 Oct;35(9):533-42. doi: 10.1007/s11626-999-0064-y. In Vitro Cell Dev Biol Anim. 1999. PMID: 10548435
-
Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model.Cytotherapy. 2009;11(6):726-37. doi: 10.3109/14653240903067299. Cytotherapy. 2009. PMID: 19878059 Free PMC article.
-
Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor.Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10010-5. doi: 10.1073/pnas.0704179104. Epub 2007 Jun 4. Proc Natl Acad Sci U S A. 2007. PMID: 17548836 Free PMC article.
-
Regulation of VEGF-induced endothelial cell PAF synthesis: role of p42/44 MAPK, p38 MAPK and PI3K pathways.Br J Pharmacol. 2001 Nov;134(6):1253-62. doi: 10.1038/sj.bjp.0704367. Br J Pharmacol. 2001. PMID: 11704645 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources